Literature DB >> 26215600

Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.

Carsten Stephan1, Henning Cammann2, Klaus Jung3.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26215600     DOI: 10.1016/j.eururo.2015.07.028

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

Review 1.  [Molecular biomarkers and prognostic factors for prostate cancer].

Authors:  A Kretschmer; Y Tolkach; J Ellinger; G Kristiansen
Journal:  Urologe A       Date:  2017-07       Impact factor: 0.639

Review 2.  Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.

Authors:  Xavier Filella; Laura Foj
Journal:  Int J Mol Sci       Date:  2016-10-26       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.